VAN ECK ASSOCIATES CORP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,693
+5.5%
96,465
-0.3%
0.03%
+8.3%
Q2 2023$11,085
-13.0%
96,791
+4.7%
0.02%
-17.2%
Q1 2023$12,740
+5909.4%
92,434
+5556.9%
0.03%
+2800.0%
Q4 2022$212
-99.8%
1,634
+41.6%
0.00%
Q3 2022$128,000
-93.4%
1,154
-95.6%
0.00%
-100.0%
Q1 2021$1,953,000
-88.1%
26,209
-72.8%
0.01%
-89.6%
Q4 2020$16,424,000
-37.7%
96,335
-48.7%
0.05%
+14.3%
Q3 2020$26,372,000
-22.5%
187,792
-11.6%
0.04%
-28.8%
Q2 2020$34,044,000
+352.4%
212,328
+176.0%
0.06%
+55.3%
Q1 2020$7,526,000
-41.7%
76,934
-23.1%
0.04%
-24.0%
Q4 2019$12,909,000
+69.1%
100,038
-1.3%
0.05%
+38.9%
Q3 2019$7,634,000
-47.9%
101,352
+5.1%
0.04%
-49.3%
Q2 2019$14,654,000
-1.8%
96,440
-23.0%
0.07%
-2.7%
Q1 2019$14,927,000
+10.0%
125,235
+0.7%
0.07%
+7.4%
Q4 2018$13,568,000
-22.6%
124,325
+14.5%
0.07%
-20.9%
Q3 2018$17,534,000108,5620.09%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders